|
|
CRNX
|
Stock |
Healthcare
|
US$ 9.01 B
|
3,61% |
|
|
ATAI
|
Stock |
Healthcare
|
US$ 2.72 B
|
2,83% |
|
|
PCRX
|
Stock |
Healthcare
|
US$ 1.45 B
|
2,68% |
|
|
LLY
|
Stock |
Healthcare
|
US$ 1.26 T
|
2,64% |
|
Veradermics, Incorporated
|
MANE
|
Stock |
Healthcare
|
US$ 5.58 B
|
2,56% |
|
|
XERS
|
Stock |
Healthcare
|
US$ 1.89 B
|
2,55% |
Amneal Pharmaceuticals, Inc. Class A Common Stock
|
AMRX
|
Stock |
Healthcare
|
US$ 6.95 B
|
2,46% |
|
|
VTRS
|
Stock |
Healthcare
|
US$ 21.73 B
|
2,37% |
|
|
RPRX
|
Stock |
Healthcare
|
US$ 38.37 B
|
2,33% |
|
|
PRGO
|
Stock |
Healthcare
|
US$ 2.17 B
|
2,32% |
|
|
LGND
|
Stock |
Healthcare
|
US$ 6.27 B
|
2,23% |
|
Indivior PLC Ordinary Shares
|
INDV
|
Stock |
Healthcare
|
US$ 4.28 B
|
2,22% |
|
|
ZTS
|
Stock |
Healthcare
|
US$ 34.29 B
|
2,22% |
|
|
JNJ
|
Stock |
Healthcare
|
US$ 640.75 B
|
2,16% |
Maze Therapeutics, Inc. Common Stock
|
MAZE
|
Stock |
Healthcare
|
US$ 1.79 B
|
2,16% |
|
|
OGN
|
Stock |
Healthcare
|
US$ 3.64 B
|
2,15% |
|
|
PFE
|
Stock |
Healthcare
|
US$ 170.99 B
|
2,13% |
|
|
COLL
|
Stock |
Healthcare
|
US$ 772.54 M
|
2,09% |
Septerna, Inc. Common Stock
|
SEPN
|
Stock |
Healthcare
|
US$ 2.23 B
|
2,07% |
|
|
INVA
|
Stock |
Healthcare
|
US$ 1.51 B
|
2,07% |
|
|
ELAN
|
Stock |
Healthcare
|
US$ 12.65 B
|
2,05% |
|
|
BMY
|
Stock |
Healthcare
|
US$ 131.21 B
|
2,05% |
|
|
SUPN
|
Stock |
Healthcare
|
US$ 1.64 B
|
2,04% |
Prestige Brand Holdings Inc
|
PBH
|
Stock |
Healthcare
|
US$ 2.52 B
|
2,04% |
|
|
MRK
|
Stock |
Healthcare
|
US$ 356.93 B
|
2,02% |
|
|
ANIP
|
Stock |
Healthcare
|
US$ 1.65 B
|
2,00% |
|
|
NKTR
|
Stock |
Healthcare
|
US$ 2.53 B
|
1,83% |
|
|
OMER
|
Stock |
Healthcare
|
US$ 1.32 B
|
1,83% |
|
|
AMLX
|
Stock |
Healthcare
|
US$ 3.66 B
|
1,82% |
|
|
EWTX
|
Stock |
Healthcare
|
US$ 4.09 B
|
1,81% |
|
|
HRMY
|
Stock |
Healthcare
|
US$ 2.16 B
|
1,79% |
|
|
ETON
|
Stock |
Healthcare
|
US$ 1.45 B
|
1,78% |
|
|
JAZZ
|
Stock |
Healthcare
|
US$ 14.91 B
|
1,77% |
|
|
TARS
|
Stock |
Healthcare
|
US$ 3.40 B
|
1,74% |
|
|
TRVI
|
Stock |
Healthcare
|
US$ 1.97 B
|
1,69% |
|
MBX Biosciences, Inc. Common Stock
|
MBX
|
Stock |
Healthcare
|
US$ 2.65 B
|
1,69% |
|
|
DFTX
|
Stock |
Healthcare
|
US$ 4.49 B
|
1,69% |
|
|
AMPH
|
Stock |
Healthcare
|
US$ 1.15 B
|
1,68% |
Enliven Therapeutics Inc.
|
ELVN
|
Stock |
Healthcare
|
US$ 3.46 B
|
1,63% |
|
|
HROW
|
Stock |
Healthcare
|
US$ 1.07 B
|
1,47% |
|
|
KMPH
|
Stock |
Healthcare
|
US$ 200.47 M
|
1,43% |
|
|
CORT
|
Stock |
Healthcare
|
US$ 8.56 B
|
1,43% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX
|
Stock |
Healthcare
|
US$ 1.30 B
|
1,40% |
|
|
NUVB
|
Stock |
Healthcare
|
US$ 1.65 B
|
1,36% |
|
|
WVE
|
Stock |
Healthcare
|
US$ 706.08 M
|
1,33% |
Alumis Inc
|
ALMS
|
Stock |
Healthcare
|
US$ 847.80 M
|
1,30% |
|
|
AXSM
|
Stock |
Healthcare
|
US$ 7.34 B
|
1,30% |
|
|
PAHC
|
Stock |
Healthcare
|
US$ 1.60 B
|
1,26% |
|
|
OCUL
|
Stock |
Healthcare
|
US$ 1.50 B
|
1,19% |
|
|
LQDA
|
Stock |
Healthcare
|
US$ 4.24 B
|
1,18% |
Alto Neuroscience, Inc.
|
ANRO
|
Stock |
Healthcare
|
US$ 890.80 M
|
1,08% |
Rapport Therapeutics, Inc. Common Stock
|
RAPP
|
Stock |
Healthcare
|
US$ 1.47 B
|
1,03% |
|
|
RLMD
|
Stock |
Healthcare
|
US$ 455.48 M
|
1,02% |
|
|
PHAT
|
Stock |
Healthcare
|
US$ 466.61 M
|
0,98% |
|
|
AQST
|
Stock |
Healthcare
|
US$ 476.94 M
|
0,92% |
|
|
CRMD
|
Stock |
Healthcare
|
US$ 433.37 M
|
0,90% |
|
|
ACRS
|
Stock |
Healthcare
|
US$ 579.64 M
|
0,86% |
|
|
ARVN
|
Stock |
Healthcare
|
US$ 486.01 M
|
0,76% |
|
Avalyn Pharma Inc. Common Stock
|
AVLN
|
Stock |
Healthcare
|
US$ 1.19 B
|
0,75% |
|
|
EOLS
|
Stock |
Healthcare
|
US$ 493.40 M
|
0,67% |
|
|
LXRX
|
Stock |
Healthcare
|
US$ 649.64 M
|
0,61% |
BioAge Labs, Inc
|
BIOA
|
Stock |
Healthcare
|
US$ 273.09 M
|
0,60% |
Contineum Therapeutics, Inc. Class A Common Stock
|
CTNM
|
Stock |
Healthcare
|
US$ 364.55 M
|
0,48% |
|
|
EYPT
|
Stock |
Healthcare
|
US$ 33.12 M
|
0,08% |